For combination studies – clinical trials submitted to both CTIS and DMIDS – only a single radiation protection notification according to § 32 StrlSchG (Strahlenschutzgesetz (German Radiation Protection Act)) or an approval according to § 31 StrlSchG is required. This notification or application can be submitted either via CTIS or DMIDS. We recommend selecting the platform based on the specific requirements of radiation protection.